ReviewFrontiers in oncologyPublished
Clinical efficacy and safety of pembrolizumab and nivolumab in frontline treatment for classical Hodgkin lymphoma: systematic review and meta-analysis of clinical trials
Regional connection
Verified An author affiliation on the Europe PMC record names Thomas Jefferson University. Affiliation source
- Institution
- Thomas Jefferson University
- County
- Philadelphia County
Publication record
- Type
- Review
- Venue
- Frontiers in oncology
- Published
- Topic
- Clinical care
- Subject terms
- Immunotherapy; PD-1; Hodgkin Lymphoma; Nivolumab; Immune Checkpoint Inhibitors; Pembrolizumab
- PubMed ID
- 42434738
- PubMed Central ID
- PMC13349832
- Open access
- Yes, open
- Added to directory
- Source checked